US2010197823A1PendingUtilityA1

Polymeric Resorbable Composites Containing an Amorphous Calcium Phosphate Polymer Ceramic for Bone Repair and Replacement

Assignee: UNIV DREXELPriority: Mar 14, 2001Filed: Apr 9, 2010Published: Aug 5, 2010
Est. expiryMar 14, 2021(expired)· nominal 20-yr term from priority
A61F 2/28A61F 2002/30968A61L 27/50A61F 2002/30062A61F 2210/0004A61F 2310/00293A61L 27/46Y10S977/70
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for making bioresorbable composites of a non-crystalline calcium phosphate ceramic synthesized within encapsulating microspheres of bioresorbable polymeric material for use in bone repair and replacement is provided. The composites include microspheres and scaffolds produced therefrom.

Claims

exact text as granted — not AI-modified
1 . A method for producing a bioresorbable composite comprising:
 (a) contacting a basic aqueous calcium salt solution and a basic aqueous phosphate salt solution in a non-polar immiscible solvent containing at least one bioresorbable polymeric material at a temperature; and   (b) emulsifying the mixture with sufficient energy for a time and at a temperature sufficient to provide for the reaction between the calcium and phosphate salts to form a non-crystalline or amorphous calcium phosphate composition encapsulated within encapsulating microspheres of the bioresorbable polymer.   
   
   
       2 . The method of  claim 1  wherein the calcium salt is calcium nitrate, or a hydrate thereof. 
   
   
       3 . The method of  claim 1  wherein the phosphate salt is ammonium hydrogen phosphate, or a hydrate thereof. 
   
   
       4 . The method of  claim 1  wherein the basic calcium salt solution, the basic phosphate salt solution, or both comprise ammonium hydroxide. 
   
   
       5 . The method of  claim 1  wherein the non-polar immiscible solvent is methylene chloride. 
   
   
       6 . The method of  claim 1  wherein the pH of the calcium salt solution is about 10. 
   
   
       7 . The method of  claim 1  wherein the pH of the phosphate salt solution is about 10. 
   
   
       8 . The method of  claim 1  wherein the at least one bioresorbable polymeric material comprises a polylactic acid, a polyglycolic acid, a poly(lactic acid-glycolic acid), a polyanhydride, a poly(phosphazene), a poly(orthoester), a poly(caprolactone), a polyhydroxybutyrate, a polyanhydrideco-imide, a polypropylene fumarate, a polydiaxonane, or a polyurethane polymer, or any copolymer or mixture thereof. 
   
   
       9 . The bioresorbable composite of  claim 1 , wherein the bioresorbable polymeric material comprises a polylactic acid, a polyglycolic acid, a poly(lactic acid-glycolic acid) polymer or any copolymer or mixture thereof. 
   
   
       10 . The method of  claim 1  wherein the temperature is below room temperature. 
   
   
       11 . The method of  claim 1  wherein the temperature is about −70° C. 
   
   
       12 . The method of  claim 1  further comprising adding the emulsion to a mixed solution of a surfactant and a calcium salt. 
   
   
       13 . The method of  claim 12  wherein the surfactant is poly(vinyl alcohol). 
   
   
       14 . The method of  claim 1  further comprising separating the encapsulated microspheres of bioresorbable polymer from unencapsulated calcium phosphate and unencapsulating microspheres. 
   
   
       15 . The method of  claim 1  wherein the calcium phosphate composition is characterized by an x-ray diffraction pattern indicative of an amorphous or poorly crystalline material. 
   
   
       16 . The method of  claim 1 , wherein the calcium phosphate composition is characterized as having a stoichiometry approximately that of hydroxyapatite, calcium phosphate, tricalcium phosphate, tetracalcium phosphate, bone apatite, or any combination thereof. 
   
   
       17 . The method of  claim 1 , wherein the calcium phosphate composition is characterized as having a stoichiometry approximately that of bone apatite. 
   
   
       18 . The method of  claim 1 , wherein the calcium phosphate composition additionally comprises carbonated calcium phosphate. 
   
   
       19 . The method of  claim 1  wherein the bioresorbable microspheres are characterized as having a diameter between about 100 and about 250 microns. 
   
   
       20 . The method of  claim 1  wherein the bioresorbable polymeric microsphere contain approximately 28 weight percent or more of the non-crystalline, poorly crystalline, or amorphous calcium phosphate ceramic relative to the mass of the entire composite. 
   
   
       21 . The method of  claim 1  further comprising joining a plurality of the encapsulating microspheres of the at least one bioresorbable polymeric material to form a porous three-dimensional scaffold. 
   
   
       22 . The method of  claim 1  wherein the plurality of the encapsulating microspheres of the at least one bioresorbable polymeric material are joined by sintering at a temperature above the melting point of at least one of the bioresorbable polymeric materials. 
   
   
       23 . The method of  claim 22  wherein sintering temperature is about 150° C. 
   
   
       24 . The method of  claim 21  wherein the majority of pores in the three-dimensional scaffold are characterized as having diameters of at least 100 microns. 
   
   
       25 . The method of  claim 15  wherein the porosity of the three-dimensional scaffold is about 75%. 
   
   
       26 . The method of  claim 1  or  21  wherein the bioresorbable composite is suitable for tissue repair and/or replacement applications. 
   
   
       27 . The method of  claim 26  wherein the tissue is bone.

Join the waitlist — get patent alerts

Track US2010197823A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.